GT200600125A - Nueva sal y polimorfos del inhibidor de la dpp-iv - Google Patents
Nueva sal y polimorfos del inhibidor de la dpp-ivInfo
- Publication number
- GT200600125A GT200600125A GT200600125A GT200600125A GT200600125A GT 200600125 A GT200600125 A GT 200600125A GT 200600125 A GT200600125 A GT 200600125A GT 200600125 A GT200600125 A GT 200600125A GT 200600125 A GT200600125 A GT 200600125A
- Authority
- GT
- Guatemala
- Prior art keywords
- polymorphes
- dpp
- inhibitor
- new salt
- salt
- Prior art date
Links
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 title abstract 2
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A NUEVA SAL Y POLIMORFOS DEL INHIBIDOR DE LA DPP-IV. ESTE COMPUESTO Y SUS FORMAS POLIMÓRFICAS POSEEN PROPIEDADES SUPERIORES SI SE COMPARAN CON LOS COMPUESTOS CONOCIDOS ANTERIORMENTE Y PUEDEN UTILIZARSE COMO MEDICAMENTOS EN CUADROS DE DIABETES, COLITIS ULCEROSA, OBESIDAD, ENTRE OTROS DESCRITOS EN EL EXPEDIENTE. T2006
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05102251 | 2005-03-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200600125A true GT200600125A (es) | 2007-03-16 |
Family
ID=36406081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200600125A GT200600125A (es) | 2005-03-22 | 2006-03-22 | Nueva sal y polimorfos del inhibidor de la dpp-iv |
Country Status (17)
Country | Link |
---|---|
US (1) | US7772264B2 (es) |
EP (1) | EP1888571A2 (es) |
JP (1) | JP5043825B2 (es) |
KR (1) | KR20070113305A (es) |
CN (1) | CN101146801A (es) |
AR (1) | AR055570A1 (es) |
AU (1) | AU2006226447B2 (es) |
BR (1) | BRPI0609580A2 (es) |
CA (1) | CA2600203C (es) |
DO (1) | DOP2006000066A (es) |
GT (1) | GT200600125A (es) |
IL (1) | IL185768A0 (es) |
MX (1) | MX2007011546A (es) |
PA (1) | PA8666701A1 (es) |
PE (1) | PE20061109A1 (es) |
TW (1) | TW200700415A (es) |
WO (1) | WO2006100181A2 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20090938A1 (es) | 2007-08-16 | 2009-08-08 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
US20110190322A1 (en) | 2008-08-14 | 2011-08-04 | Boehringer Ingelheim International Gmbh | Purin derivatives for use in the treatment of fab-related diseases |
CZ2008512A3 (cs) | 2008-08-26 | 2010-03-10 | Zentiva, A. S | Zpusob prípravy vysoce cistého vildagliptinu |
AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
TWI466672B (zh) | 2009-01-29 | 2015-01-01 | Boehringer Ingelheim Int | 小兒科病人糖尿病之治療 |
AU2010212823B2 (en) | 2009-02-13 | 2016-01-28 | Boehringer Ingelheim International Gmbh | Antidiabetic medications comprising a DPP-4 inhibitor (linagliptin) optionally in combination with other antidiabetics |
AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
CN102753161A (zh) | 2009-11-27 | 2012-10-24 | 贝林格尔.英格海姆国际有限公司 | 基因型糖尿病患者利用dpp-iv抑制剂例如利拉利汀的治疗 |
US20130109703A1 (en) | 2010-03-18 | 2013-05-02 | Boehringer Ingelheim International Gmbh | Combination of a GPR119 Agonist and the DPP-IV Inhibitor Linagliptin for Use in the Treatment of Diabetes and Related Conditions |
JP2013523819A (ja) | 2010-04-06 | 2013-06-17 | アリーナ ファーマシューティカルズ, インコーポレイテッド | Gpr119レセプターのモジュレーターおよびそれに関連する障害の処置 |
WO2011138421A1 (en) | 2010-05-05 | 2011-11-10 | Boehringer Ingelheim International Gmbh | Combination therapy |
EP3124041A1 (en) | 2010-06-24 | 2017-02-01 | Boehringer Ingelheim International GmbH | Diabetes therapy |
KR101871011B1 (ko) | 2010-09-22 | 2018-06-25 | 아레나 파마슈티칼스, 인크. | Gpr119 수용체의 조절제 및 그와 관련된 장애의 치료 |
WO2012135570A1 (en) | 2011-04-01 | 2012-10-04 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US20140038889A1 (en) | 2011-04-22 | 2014-02-06 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
CN103787944A (zh) * | 2012-11-01 | 2014-05-14 | 天津药物研究院 | 1-(2-氯乙酰基)-2-(s)-腈基吡咯烷的制备方法 |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
CN104262227B (zh) * | 2014-09-16 | 2018-09-18 | 东北制药集团股份有限公司 | 一种制备(s)-1-(2-氯乙酰基)吡咯烷-2-甲腈的方法 |
CA2979033A1 (en) | 2015-03-09 | 2016-09-15 | Intekrin Therapeutics, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
CN106699627A (zh) * | 2016-12-29 | 2017-05-24 | 青岛黄海制药有限责任公司 | 一种多相复式非连续生产法制备1‑(2‑氯乙酰基)‑2‑(s)‑氰基吡咯烷的方法 |
US11253508B2 (en) | 2017-04-03 | 2022-02-22 | Coherus Biosciences, Inc. | PPARy agonist for treatment of progressive supranuclear palsy |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07247246A (ja) * | 1994-03-09 | 1995-09-26 | Daicel Chem Ind Ltd | 1−フェニル−3−ブチン誘導体とその製造方法 |
TW492957B (en) * | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
DK0921125T3 (da) * | 1997-12-05 | 2002-05-13 | Hoffmann La Roche | 1,3,8-triazaspiro[4.5]decan-4-on-derivater |
DE19755436A1 (de) | 1997-12-13 | 1999-06-24 | Beiersdorf Ag | Verfahren zur zumindest partiellen direkten Beschichtung eines dehnfähigen Trägermaterials mit einer Haftklebemasse |
RU2180663C2 (ru) * | 1998-03-30 | 2002-03-20 | Джапан Тобакко Инк. | Способ получения изоксазолидиндионового соединения, способ получения оксазолилэтанольного соединения (варианты), способ получения аспартатного соединения, способ получения оксазолилацетатного соединения, способ получения метансульфонатного соединения, способ получения бензилиденового соединения |
US6861440B2 (en) * | 2001-10-26 | 2005-03-01 | Hoffmann-La Roche Inc. | DPP IV inhibitors |
WO2003040114A1 (en) * | 2001-11-06 | 2003-05-15 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
JP3746063B2 (ja) * | 2002-08-29 | 2006-02-15 | 大正製薬株式会社 | 4−フルオロ−2−シアノピロリジン誘導体ベンゼンスルホン酸塩 |
GB0313661D0 (en) * | 2003-06-13 | 2003-07-16 | Avecia Ltd | Process |
-
2006
- 2006-03-09 BR BRPI0609580-1A patent/BRPI0609580A2/pt not_active IP Right Cessation
- 2006-03-09 JP JP2008502373A patent/JP5043825B2/ja not_active Expired - Fee Related
- 2006-03-09 MX MX2007011546A patent/MX2007011546A/es active IP Right Grant
- 2006-03-09 CA CA2600203A patent/CA2600203C/en not_active Expired - Fee Related
- 2006-03-09 WO PCT/EP2006/060589 patent/WO2006100181A2/en not_active Application Discontinuation
- 2006-03-09 EP EP06724997A patent/EP1888571A2/en not_active Withdrawn
- 2006-03-09 CN CNA2006800090213A patent/CN101146801A/zh active Pending
- 2006-03-09 AU AU2006226447A patent/AU2006226447B2/en not_active Ceased
- 2006-03-09 KR KR1020077024075A patent/KR20070113305A/ko active Search and Examination
- 2006-03-16 US US11/376,862 patent/US7772264B2/en not_active Expired - Fee Related
- 2006-03-20 PE PE2006000304A patent/PE20061109A1/es not_active Application Discontinuation
- 2006-03-20 AR ARP060101079A patent/AR055570A1/es not_active Application Discontinuation
- 2006-03-21 DO DO2006000066A patent/DOP2006000066A/es unknown
- 2006-03-21 TW TW095109702A patent/TW200700415A/zh unknown
- 2006-03-21 PA PA20068666701A patent/PA8666701A1/es unknown
- 2006-03-22 GT GT200600125A patent/GT200600125A/es unknown
-
2007
- 2007-09-06 IL IL185768A patent/IL185768A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW200700415A (en) | 2007-01-01 |
AU2006226447A1 (en) | 2006-09-28 |
AU2006226447B2 (en) | 2009-07-16 |
US20060217428A1 (en) | 2006-09-28 |
IL185768A0 (en) | 2008-01-06 |
CA2600203A1 (en) | 2006-09-28 |
JP5043825B2 (ja) | 2012-10-10 |
JP2008534470A (ja) | 2008-08-28 |
DOP2006000066A (es) | 2006-09-30 |
CN101146801A (zh) | 2008-03-19 |
AR055570A1 (es) | 2007-08-22 |
MX2007011546A (es) | 2007-10-19 |
US7772264B2 (en) | 2010-08-10 |
BRPI0609580A2 (pt) | 2010-04-20 |
EP1888571A2 (en) | 2008-02-20 |
PE20061109A1 (es) | 2006-10-13 |
WO2006100181A2 (en) | 2006-09-28 |
WO2006100181A3 (en) | 2006-11-30 |
PA8666701A1 (es) | 2006-12-07 |
KR20070113305A (ko) | 2007-11-28 |
CA2600203C (en) | 2012-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200600125A (es) | Nueva sal y polimorfos del inhibidor de la dpp-iv | |
DE502007004290D1 (de) | Carbazol-derivate für organische elektrolumineszenzvorrichtungen | |
CR9399S (es) | Contenedor | |
NI200700169A (es) | Derivados del pirimidinil y piridinil sustituidos como moduladores del metabolismo y el tratamiento de desordenes relacionados con el mismo. | |
ECSP10010722A (es) | Compuestos orgánicos | |
TW201129567A (en) | Materials for organic electroluminescent devices | |
CR9611S (es) | Contenedor | |
NI201100049A (es) | Compuestos orgánicos. | |
CO6670585A2 (es) | Promotores de apotosis n-acilsufonamidas | |
NI201200023A (es) | Derivados de 5-fluoropirimidinona | |
PL2126020T3 (pl) | Hydrofobowo modyfikowane polialkilenoiminy jako inhibitory przenoszenia barwnika | |
CL2011000846A1 (es) | Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c. | |
CL2008002369A1 (es) | Compuestos derivados de piridin-3-il-oxipiridin-2-il-amino, inhibidores de alk5; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del cancer. | |
EA201000272A1 (ru) | Трициклические мостиковые производные циклопентадиенона, как гербициды | |
CL2007002890A1 (es) | Compuestos derivados de 2-piridincarboxamida, activador de glucosinasa; composicion farmaceutica; y uso del compuesto para el tratamiento de diabetes o la obesidad. | |
BRPI0814772A2 (pt) | Indazóis substituídos por 5-piridinona | |
ECSP10010058A (es) | Derivados de quinazolinadiona, su preparación y sus aplicaciones terapéuticas | |
CR9619S (es) | Contenedor y cierre | |
ECSP21011232A (es) | Nuevo derivado de amina heterocíclico y composición farmacéutica que lo comprende | |
GT200700074A (es) | Fungicidas | |
CL2009000599A1 (es) | Compuestos derivados de 4,5-dihidro-1h-pirazol(4,3-g)benzotiazol sustituidos; composicion farmaceutica; utiles para el tratamiento y prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunes, entre otras. | |
DOP2020000077A (es) | Nuevo derivado de fenilpiridina y composición farmacéutica que lo contiene | |
CR9613S (es) | Contenedor | |
CR9397S (es) | Contenedor | |
CR11449A (es) | Productos intermedios gsm |